Jasmien Cornillie

595 total citations
27 papers, 471 citations indexed

About

Jasmien Cornillie is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jasmien Cornillie has authored 27 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jasmien Cornillie's work include Sarcoma Diagnosis and Treatment (23 papers), Vascular Tumors and Angiosarcomas (11 papers) and Cardiac tumors and thrombi (8 papers). Jasmien Cornillie is often cited by papers focused on Sarcoma Diagnosis and Treatment (23 papers), Vascular Tumors and Angiosarcomas (11 papers) and Cardiac tumors and thrombi (8 papers). Jasmien Cornillie collaborates with scholars based in Belgium, United States and Switzerland. Jasmien Cornillie's co-authors include Patrick Schöffski, Agnieszka Woźniak, Daphne Hompes, Maria Dêbiec‐Rychter, Raf Sciot, Haifu Li, Jasmien Wellens, Yemarshet K. Gebreyohannes, Ulla Vanleeuw and Thomas Van Looy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jasmien Cornillie

27 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jasmien Cornillie Belgium	14	330	211	111	87	84	27	471
Mercedes M. Condy United States	8	328 1.0×	252 1.2×	61 0.5×	105 1.2×	71 0.8×	15	456
Bart Rikhof Netherlands	11	227 0.7×	114 0.5×	80 0.7×	159 1.8×	47 0.6×	14	490
Ulla Vanleeuw Belgium	11	234 0.7×	139 0.7×	165 1.5×	92 1.1×	18 0.2×	22	400
Dominique Vince-Ranchère France	4	292 0.9×	150 0.7×	34 0.3×	114 1.3×	60 0.7×	4	397
Jean‐François Goussot France	7	323 1.0×	221 1.0×	20 0.2×	37 0.4×	90 1.1×	9	472
Thibaud Valentin France	12	324 1.0×	202 1.0×	13 0.1×	72 0.8×	83 1.0×	38	505
Vanessa Vanspauwen Belgium	9	229 0.7×	96 0.5×	25 0.2×	82 0.9×	66 0.8×	13	333
Anna Felisiak-Gołąbek Poland	14	206 0.6×	200 0.9×	72 0.6×	156 1.8×	9 0.1×	20	544
Emanuela Virdis Italy	8	433 1.3×	152 0.7×	19 0.2×	129 1.5×	86 1.0×	10	589
Mihaela Druta United States	14	255 0.8×	252 1.2×	12 0.1×	63 0.7×	65 0.8×	43	437

Countries citing papers authored by Jasmien Cornillie

Since Specialization

Citations

This map shows the geographic impact of Jasmien Cornillie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmien Cornillie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmien Cornillie more than expected).

Fields of papers citing papers by Jasmien Cornillie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmien Cornillie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmien Cornillie. The network helps show where Jasmien Cornillie may publish in the future.

Co-authorship network of co-authors of Jasmien Cornillie

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmien Cornillie. A scholar is included among the top collaborators of Jasmien Cornillie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmien Cornillie. Jasmien Cornillie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woźniak, Agnieszka, Jasmien Cornillie, Pablo Avilés, et al.. (2022). Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma. International Journal of Molecular Sciences. 23(13). 7454–7454. 3 indexed citations

Cornillie, Jasmien, Agnieszka Woźniak, Haifu Li, et al.. (2019). Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing. Molecular Cancer Therapeutics. 18(6). 1168–1178. 27 indexed citations

Cornillie, Jasmien, Agnieszka Woźniak, Yemarshet K. Gebreyohannes, et al.. (2019). Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification. Clinical & Translational Oncology. 22(4). 546–554. 46 indexed citations

Cornillie, Jasmien, Thomas Van Cann, Agnieszka Woźniak, et al.. (2019). Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center. Oncology Research and Treatment. 42(7-8). 396–404. 15 indexed citations

Cornillie, Jasmien, Agnieszka Woźniak, Jasmien Wellens, et al.. (2019). Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts. BMC Cancer. 19(1). 724–724. 5 indexed citations

Schöffski, Patrick, Jasmien Cornillie, Yemarshet K. Gebreyohannes, et al.. (2019). XenoSarc: A comprehensive platform of patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) for early drug testing.. Journal of Global Oncology. 5(suppl). 37–37. 2 indexed citations

Gebreyohannes, Yemarshet K., Elizabeth A. Burton, Agnieszka Woźniak, et al.. (2018). PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors. Clinical and Experimental Medicine. 19(2). 201–210. 15 indexed citations

Gebreyohannes, Yemarshet K., Agnieszka Woźniak, Jasmien Wellens, et al.. (2018). Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors. Clinical Cancer Research. 25(2). 609–618. 57 indexed citations

Cornillie, Jasmien, Agnieszka Woźniak, Maria Dêbiec‐Rychter, et al.. (2018). Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center. Oncology Research and Treatment. 41(4). 206–213. 14 indexed citations

10.

Cornillie, Jasmien, Agnieszka Woźniak, Péter Pokreisz, et al.. (2017). In Vivo Antitumoral Efficacy of PhAc-ALGP-Doxorubicin, an Enzyme-Activated Doxorubicin Prodrug, in Patient-Derived Soft Tissue Sarcoma Xenograft Models. Molecular Cancer Therapeutics. 16(8). 1566–1575. 16 indexed citations

11.

Sciot, Raf, Marion Delcroix, Maria Dêbiec‐Rychter, et al.. (2017). Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy. Oncology Research and Treatment. 40(6). 353–359. 20 indexed citations

12.

Gebreyohannes, Yemarshet K., Patrick Schöffski, Thomas Van Looy, et al.. (2016). Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT Mutations. Molecular Cancer Therapeutics. 15(12). 2845–2852. 29 indexed citations

13.

Cornillie, Jasmien, Thomas Van Cann, Agnieszka Woźniak, Daphne Hompes, & Patrick Schöffski. (2016). Biology and management of clear cell sarcoma: state of the art and future perspectives. Expert Review of Anticancer Therapy. 16(8). 839–845. 28 indexed citations

14.

Woźniak, Agnieszka, Thomas Van Looy, Giuseppe Floris, et al.. (2015). Abstract 1461: A panel of patient derived gastrointestinal stromal tumors (GIST) xenograft models for in vivo preclinical drug testing. Cancer Research. 75(15_Supplement). 1461–1461. 1 indexed citations

15.

Gebreyohannes, Yemarshet K., Agnieszka Woźniak, Thomas Van Looy, et al.. (2015). PLX9486 shows anti-tumor efficacy in a patient-derived gastrointestinal stromal tumor (GIST) xenograft model resistant to standard tyrosine kinase inhibitors (TKI). 1 indexed citations

16.

Li, Haifu, Agnieszka Woźniak, Raf Sciot, et al.. (2014). Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models. Translational Oncology. 7(6). 665–671. 36 indexed citations

17.

Looy, Thomas Van, Yemarshet K. Gebreyohannes, Agnieszka Woźniak, et al.. (2014). Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors. PubMed. 4(1). 10–10. 22 indexed citations

18.

Schöffski, Patrick, Jasmien Cornillie, Agnieszka Woźniak, Haifu Li, & Daphne Hompes. (2014). Soft Tissue Sarcoma: An Update on Systemic Treatment Options for Patients with Advanced Disease. Oncology Research and Treatment. 37(6). 355–362. 81 indexed citations

19.

Gheysens, Olivier, Jasmien Cornillie, Jens‐Uwe Voigt, Jan Bogaert, & René Westhovens. (2013). Left Atrial Myxoma on FDG-PET/CT. Clinical Nuclear Medicine. 38(11). e421–e422. 13 indexed citations

20.

Cornillie, Jasmien, Thomas Tousseyn, & Gregor Verhoef. (2012). T-cell/histiocyte-rich large B-cell lymphoma: review on pathologic diagnosis, current therapeutic options and new targets for therapy. 3(4). 128–133. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact